She has more than 15 years of food and drug legal, policy, and regulatory experience at the FDA, on Capitol Hill, and in the private sector
2021;44(Suppl1):S111s124
The STEP (Semaglutide Treatment Effect in People with obesity) trials, which included over 4,500 participants, showed that semaglutide 2.4 mg weekly resulted in mean weight loss of 12.4% to 15.3% of initial body weight over 68 weeks, compared to 2.4% to 3.2% with placebo
These enhancements across youth, middle age, and old age suggest MOTS-c can benefit muscle performance regardless of baseline fitness
Baseline diet and metabolic status People who eat large portions of highly processed, calorie-dense food before starting semaglutide often notice appetite changes more dramatically because the contrast is stark